Scientific article
OA Policy
English

Lung cancer mortality risk among breast cancer patients treated with anti-estrogens

Published in

Cancer, vol. 117, no. 6, p. 1288-1295

Publication date

2011

Abstract

The Women's Health Initiative randomized clinical trial reported that menopausal hormone therapy increases lung cancer mortality risk. If this is true, use of anti-estrogens should be associated with decreased lung cancer mortality risk. The authors compared lung cancer incidence and mortality among breast cancer patients with and without anti-estrogen therapy.

Keywords

  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents/therapeutic use
  • Breast Neoplasms/complications/drug therapy/mortality
  • Carcinoma/complications/drug therapy/mortality
  • Cohort Studies
  • Estrogen Receptor Modulators/therapeutic use
  • Female
  • Humans
  • Incidence
  • Lung Neoplasms/complications/drug therapy/etiology/mortality
  • Middle Aged
  • Registries
  • Risk Factors

Citation (ISO format)

BOUCHARDY MAGNIN, Christine et al. Lung cancer mortality risk among breast cancer patients treated with anti-estrogens. In: Cancer, 2011, vol. 117, n° 6, p. 1288–1295. doi: 10.1002/cncr.25638

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

0008-543X
727views
564downloads

Technical informations

Creation

20/11/2012 14:17:00

First validation

20/11/2012 14:17:00

Update

14/03/2023 17:46:46

Status update

14/03/2023 17:46:46

Last indexation

30/10/2024 08:01:41
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated